Fig. 6

Potentials of of ZnONPs nanocomposites treatment on EAC cells in EAC-challenged mice treated with ZnONPs nanocomposites. EAC-challenged mice IP inoculated with PBS, DOX (0.4 mg), ZnONPs (0.5 mg), ZnONPs/DOX (0.7 mg), ZnONPs/FA (0.5 mg) or ZnONPs /DOX/FA (0.8 mg). Ascitic EAC cells were harvested from peritoneal cavity and washed twice with PBS. Data were represented as mean ± SD (n = 10). Difference between groups was considered statistically significant at P < 0.05. Note: ^a,b Statistically significant difference as compared to the corresponding means of EAC group (b), the DOX group (c) within each column